1-(3-chloro-5-((4-(4-chloro-2-thienyl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)-2-pyridyl)piperidine-4-carboxylic acid,
AKR 501,
AKR-501,
AKR501,
avatrombopag,
E5501 compound,
YM 477,
YM-477,
YM477,
AVATROMBOPAG,
570406-98-3,
AKR-501,
UNII-3H8GSZ4SQL,
YM477,
E5501,
3H8GSZ4SQL,
AS 1670542,
1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-4-piperidinecarboxylic acid,
Avatrombopag [USAN:INN],
Doptelet,
AKR 501,
YM 477,
Avatrombopag (USAN/INN),
E 5501,
SCHEMBL289354,
GTPL9953,
CHEMBL2103883,
DTXSID30205667,
BCP28031,
ZINC72190218,
AKOS027323962,
CS-3397,
DB11995,
SB16846,
HY-13463,
FT-0728753,
A14087,
D10306,
AKR-501;E5501;AS1670542,
1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid,
1-[3-Chloro-5-[[4-(4-chloro-2-thienyl)-5-(4-cyclohexylpiperazino)-2-thiazolyl]carbamoyl]-2-pyridyl]piperidine-4-carboxylic acid,
1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic acid,
4-Piperidinecarboxylic acid, 1-(3-chloro-5-(((4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl)amino)carbonyl)-2-pyridinyl)-,
Avatrombopag [USAN],
CID9852519,
CID 9852519,